Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens

Starts:  Jul 11, 2022 08:15:00 AM (CT)
Ends:  Jul 13, 2022 03:00:00 PM (CT)
Event description
In-person or virtual attendance, free course will be held at The University of Nebraska Medical Center – Global Center for Health Security in Omaha, Nebraska. This two and one half-day interactive course allows participants to enhance knowledge and integrate practical considerations for the planning and operation of clinical research protocols involving medical countermeasures for high consequence pathogens. Course participants acquire knowledge through innovative learning platforms and problem-based scenarios that help identify and mitigate barriers to data quality and integrity in domestic and international barrier nursing environments.. • Learn from world-renowned faculty members. • Utilize best practices for clinical trials during an outbreak involving High Consequence Pathogens (HCPs). • Recognize and prevent potential risks to data quality and integrity. • Enhance cultural awareness and diversity involving clinical trials in geographic locations where the incidence of diseases caused by HCPs is high. • Earn CEs.

Contact

Robert Gump
301-326-6462
robert.gump@fda.hhs.gov